Jubilant Pharmova has informed about the appointment of Daniel J. O’Connor as CEO of Jubilant Therapeutics Inc. step down subsidiary of the Company. The company has enclosed the details. Date and Time of receipt - December 1, 2025, 08:00 PM (IST).
The above information is a part of company’s filings submitted to BSE.